A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy: A case report

Angiology

Volumn 51, Issue 8, 2000, Pages 695-697

  Ozdemir, O ^a   Boran, M ^a   Gokce, V ^a   Uzun, Y ^a   Kocak, B ^a   Korkmaz, S ^a  

^a NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CERIVASTATIN; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CAUSE OF DEATH; DRUG INDUCED DISEASE; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MUSCLE INJURY; RHABDOMYOLYSIS;

ANTILIPEMIC AGENTS; DIABETES MELLITUS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FATAL OUTCOME; GEMFIBROZIL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; KIDNEY FAILURE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PYRIDINES; RENAL DIALYSIS; RHABDOMYOLYSIS;

EID: 0033900967     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. The spectrum of rhabdomyolysis
2. Drug therapy
3. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy
4. Rhabdomyolysis associated with gemfibrozil-simvastatin therapy
5. Serum creatine phosphokinase (CPK) activity in disorders of heart and skeletal muscle
6. Haptoglobin-hemoglobin complex in human plasms inhibits endothelium dependent relaxation
7. Rhabdomyolysis and myoglobinuria
8. Preclinical and clinical pharmacology of cerivastatin
9. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia
10. Rhabdomyolysis and renal failure associated with cerivastatin- gemfibrozil combination therapy